Mutation in the Jak Kinase JH2 Domain Hyperactivates Drosophila and Mammalian Jak-Stat Pathways

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 1997 Mar 1

PMID 9032284

Citations 63

Authors

H Luo

P Rose

D Barber

W P Hanratty

S Lee

T M Roberts

A D DAndrea

C R Dearolf

Affiliations

Soon will be listed here.

Abstract

The Jak (Janus) family of nonreceptor tyrosine kinases plays a critical role in cytokine signal transduction pathways. In Drosophila melanogaster, the dominant hop(Tum-l) mutation in the Hop Jak kinase causes leukemia-like and other developmental defects. Previous studies have suggested that the Hop(Tum-l) protein might be a hyperactive kinase. Here, we report on the new dominant mutation hop(T42), which causes abnormalities that are similar to but more extreme than those caused by hop(Tum-l). We determined that Hop(T42) contains a glutamic acid-to-lysine substitution at amino acid residue 695 (E695K). This residue occurs in the JH2 (kinase-like) domain and is conserved among all Jak family members. We determined that Hop(Tum-1) and Hop(T42) both hyperphosphorylated and hyperactivated D-Stat when overexpressed in Drosophila cells. Moreover, we found that the hop(T42) phenotype was partially rescued by a reduction of wild-type D-stat activity. Finally, generation of the corresponding E695K mutation in murine Jak2 resulted in increased autophosphorylation and increased activation of Stat5 in COS cells. These results demonstrate that the mutant Hop proteins do indeed have increased tyrosine kinase activity, that the mutations hyperactivate the Hop-D-Stat pathway, and that Drosophila is a relevant system for the functional dissection of mammalian Jak-Stat pathways. Finally, we propose a model for the role of the Hop-D-Stat pathway in Drosophila hematopoiesis.

Citing Articles

JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions.

Sarapultsev A, Gusev E, Komelkova M, Utepova I, Luo S, Hu D Mol Biomed. 2023; 4(1):40.

PMID: 37938494 PMC: 10632324. DOI: 10.1186/s43556-023-00151-1.

JAK3 Y841 Autophosphorylation Is Critical for STAT5B Activation, Kinase Domain Stability and Dimer Formation.

Rodriguez G, Martinez G, Negrete O, Sun S, Guo W, Xie Y Int J Mol Sci. 2023; 24(15).

PMID: 37569303 PMC: 10418363. DOI: 10.3390/ijms241511928.

Extracellular matrix protein N-glycosylation mediates immune self-tolerance in .

Mortimer N, Fischer M, Waring A, Kr P, Kacsoh B, Brantley S Proc Natl Acad Sci U S A. 2021; 118(39).

PMID: 34544850 PMC: 8488588. DOI: 10.1073/pnas.2017460118.

Janus Kinases in Leukemia.

Raivola J, Haikarainen T, Abraham B, Silvennoinen O Cancers (Basel). 2021; 13(4).

PMID: 33672930 PMC: 7918039. DOI: 10.3390/cancers13040800.

The S1A protease family members and regulate cellular immunity in .

Kr P, Lee J, Mortimer N MicroPubl Biol. 2021; 2021.

PMID: 33644706 PMC: 7900826. DOI: 10.17912/micropub.biology.000370.

References

Chinkers M, Garbers D . The protein kinase domain of the ANP receptor is required for signaling. Science. 1989; 245(4924):1392-4. DOI: 10.1126/science.2571188. View

Krasnow M, Saffman E, Kornfeld K, Hogness D . Transcriptional activation and repression by Ultrabithorax proteins in cultured Drosophila cells. Cell. 1989; 57(6):1031-43. DOI: 10.1016/0092-8674(89)90341-3. View

Andrews N, Faller D . A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991; 19(9):2499. PMC: 329467. DOI: 10.1093/nar/19.9.2499. View

Harpur A, Andres A, Ziemiecki A, Aston R, Wilks A . JAK2, a third member of the JAK family of protein tyrosine kinases. Oncogene. 1992; 7(7):1347-53. View

Velazquez L, Fellous M, Stark G, Pellegrini S . A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell. 1992; 70(2):313-22. DOI: 10.1016/0092-8674(92)90105-l. View

Sadowski H, Gilman M . Cell-free activation of a DNA-binding protein by epidermal growth factor. Nature. 1993; 362(6415):79-83. DOI: 10.1038/362079a0. View

Hanratty W, Dearolf C . The Drosophila Tumorous-lethal hematopoietic oncogene is a dominant mutation in the hopscotch locus. Mol Gen Genet. 1993; 238(1-2):33-7. DOI: 10.1007/BF00279527. View

Witthuhn B, Quelle F, Silvennoinen O, Yi T, Tang B, Miura O . JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell. 1993; 74(2):227-36. DOI: 10.1016/0092-8674(93)90414-l. View

Argetsinger L, Campbell G, Yang X, Witthuhn B, Silvennoinen O, Ihle J . Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell. 1993; 74(2):237-44. DOI: 10.1016/0092-8674(93)90415-m. View

10.

Zinyk D, McGonnigal B, Dearolf C . Drosophila awdK-pn, a homologue of the metastasis suppressor gene nm23, suppresses the Tum-1 haematopoietic oncogene. Nat Genet. 1993; 4(2):195-201. DOI: 10.1038/ng0693-195. View

11.

Miura O, Nakamura N, Ihle J, Aoki N . Erythropoietin-dependent association of phosphatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor. J Biol Chem. 1994; 269(1):614-20. View

12.

Binari R, Perrimon N . Stripe-specific regulation of pair-rule genes by hopscotch, a putative Jak family tyrosine kinase in Drosophila. Genes Dev. 1994; 8(3):300-12. DOI: 10.1101/gad.8.3.300. View

13.

Barber D, DeMartino J, Showers M, DAndrea A . A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation. Mol Cell Biol. 1994; 14(4):2257-65. PMC: 358592. DOI: 10.1128/mcb.14.4.2257-2265.1994. View

14.

Wakao H, Gouilleux F, Groner B . Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 1994; 13(9):2182-91. PMC: 395072. DOI: 10.1002/j.1460-2075.1994.tb06495.x. View

15.

Darnell Jr J, Kerr I, Stark G . Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994; 264(5164):1415-21. DOI: 10.1126/science.8197455. View

16.

Zhuang H, Patel S, He T, Niu Z, Wojchowski D . Dominant negative effects of a carboxy-truncated Jak2 mutant on Epo-induced proliferation and Jak2 activation. Biochem Biophys Res Commun. 1994; 204(1):278-83. DOI: 10.1006/bbrc.1994.2456. View

17.

Velazquez L, Mogensen K, Barbieri G, Fellous M, Uze G, Pellegrini S . Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction. J Biol Chem. 1995; 270(7):3327-34. DOI: 10.1074/jbc.270.7.3327. View

18.

Klingmuller U, Lorenz U, Cantley L, Neel B, Lodish H . Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 1995; 80(5):729-38. DOI: 10.1016/0092-8674(95)90351-8. View

19.

Azam M, Erdjument-Bromage H, Kreider B, Xia M, Quelle F, Basu R . Interleukin-3 signals through multiple isoforms of Stat5. EMBO J. 1995; 14(7):1402-11. PMC: 398225. DOI: 10.1002/j.1460-2075.1995.tb07126.x. View

20.

Luo H, Hanratty W, Dearolf C . An amino acid substitution in the Drosophila hopTum-l Jak kinase causes leukemia-like hematopoietic defects. EMBO J. 1995; 14(7):1412-20. PMC: 398227. DOI: 10.1002/j.1460-2075.1995.tb07127.x. View